Given the low levels of expression of NAA40 in normal liver, the potentially druggable nature of NAA40, the increasing incidence of liver cancers in the developed world, and the lack of efficacious cures for liver cancer, further investigations into the cancer role of this NAT in liver cancer are warranted. Here, BRD2 is linked to cancer.